The NE/AAT/CBG axis regulates adipose tissue glucocorticoid exposure
Date Available
2025-01-08Type
datasetData Creator
Nixon, MarkBoyle, Luke
Miguelez-Crespo, Allende
Paul, Mhairi
Villalobos, Elisa
Nagy, Boglarka
Homer, Natalie
Magennis, Marisa
Andrew, Ruth
Stimson, Roland
Walker, Brian
Publisher
University of Edinburgh. Edinburgh Medical School. Centre for Cardiovascular ScienceRelation (Is Referenced By)
https://doi.org/10.1038/s41467-024-55693-xMetadata
Show full item recordAltmetric
Citation
Nixon, Mark; Boyle, Luke; Miguelez-Crespo, Allende; Paul, Mhairi; Villalobos, Elisa; Nagy, Boglarka; Homer, Natalie; Magennis, Marisa; Andrew, Ruth; Stimson, Roland; Walker, Brian. (2024). The NE/AAT/CBG axis regulates adipose tissue glucocorticoid exposure, [dataset]. University of Edinburgh. Edinburgh Medical School. Centre for Cardiovascular Science. https://doi.org/10.7488/ds/7857.Description
These are the source data underlying the figures presented in the manuscript accepted in Nature Communications. These are the source data underlying the figures presented in a manuscript entitled "The NE/AAT/CBG axis regulates adipose tissue glucocorticoid exposure", which has been provisionally accepted for publication in Nature Communications. Once published, the metadata for this dataset will be updated with the DOI of the published paper. Corticosteroid binding globulin (CBG; SERPINA6) binds >85% of circulating glucocorticoids but its influence on their metabolic actions is unproven. Targeted proteolytic cleavage of CBG by neutrophil elastase (NE; ELANE) significantly reduces CBG binding affinity, potentially increasing ‘free’ glucocorticoid levels at sites of inflammation. NE is inhibited by alpha-1-antitrypsin (AAT; SERPINA1). Using complementary approaches in mice and humans to manipulate NE or AAT, we show high-fat diet (HFD) increases the NE:AAT ratio specifically in murine visceral adipose tissue, an effect only observed in males. Notably, HFD-fed male mice lacking NE have reduced glucocorticoid levels and action specifically in visceral adipose tissue, with improved glucose tolerance and insulin sensitivity, independent of systemic changes in free glucocorticoids. The protective effect of NE deficiency is lost when the adrenals are removed. Moreover, human asymptomatic heterozygous carriers of deleterious mutations in SERPINA1 resulting in lower AAT levels have increased adipose tissue glucocorticoid levels and action. However, in contrast to mice, humans present with systemic increases in free circulating glucocorticoid levels, an effect independent of HPA axis activation. These findings show that NE and AAT regulate local tissue glucocorticoid bioavailability in vivo, providing crucial evidence of a mechanism linking inflammation and metabolism.The following licence files are associated with this item: